{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:50:00Z","timestamp":1782492600603,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PID2021-129099OB-I00"],"award-info":[{"award-number":["PID2021-129099OB-I00"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FCRB_IPB 2-2023"],"award-info":[{"award-number":["FCRB_IPB 2-2023"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011100","name":"Spanish Foundation for Science and Technology","doi-asserted-by":"publisher","award":["FCT-24-20488"],"award-info":[{"award-number":["FCT-24-20488"]}],"id":[{"id":"10.13039\/501100011100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RD24\/0005\/0009"],"award-info":[{"award-number":["RD24\/0005\/0009"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RD21\/0016\/0006"],"award-info":[{"award-number":["RD21\/0016\/0006"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spanish Journal of Psychiatry and Mental Health"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.sjpmh.2026.01.002","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:15:18Z","timestamp":1770308118000},"page":"111-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of antipsychotics in children and adolescents in Spain, 2015\u20132023: A real-world, population-based study"],"prefix":"10.1016","volume":"19","author":[{"given":"Isabel","family":"Hurtado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Robles-Cabani\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anibal","family":"Garc\u00eda-Sempere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Tabar\u00e9s-Seisdedos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran","family":"Llopis-Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Gam\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Rodr\u00edguez-Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Peir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Sanf\u00e9lix-Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.sjpmh.2026.01.002_bib0145","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s00787-022-02131-2","article-title":"A systematic review and meta-analysis on the prevalence of mental disorders among children and adolescents in Europe","volume":"33","author":"Sacco","year":"2024","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.sjpmh.2026.01.002_bib0150","series-title":"The State of the World's Children 2021: On My Mind \u2013 Promoting, Protecting and Caring for Children's Mental Health","year":"2021"},{"key":"10.1016\/j.sjpmh.2026.01.002_bib0155","series-title":"Prevention and Promotion in Mental Health","year":"2002"},{"issue":"suppl 1","key":"10.1016\/j.sjpmh.2026.01.002_bib0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4088\/JCP.10075su1.01","article-title":"APs in the treatment of schizophrenia: an overview","volume":"72","author":"Tandon","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.sjpmh.2026.01.002_bib0165","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.schres.2011.05.013","article-title":"The evolution of antipsychotic switch and polypharmacy in natural practice \u2013 a longitudinal perspective","volume":"130","author":"Tsutsumi","year":"2011","journal-title":"Schizophr Res"},{"issue":"5","key":"10.1016\/j.sjpmh.2026.01.002_bib0170","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/JCP.0000000000000190","article-title":"Antipsychotic use in children and adolescents: a 1-year follow-up study","volume":"34","author":"Baeza","year":"2014","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.sjpmh.2026.01.002_bib0175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1272\/jnms.JNMS.2021_88-108","article-title":"Second-generation antipsychotic drugs for children and adolescents","volume":"88","author":"Onishi","year":"2021","journal-title":"J Nippon Med Sch"},{"issue":"9","key":"10.1016\/j.sjpmh.2026.01.002_bib0180","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s00431-022-04515-7","article-title":"Off-label use of drugs in pediatrics: a scoping review","volume":"181","author":"Meng","year":"2022","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.sjpmh.2026.01.002_bib0185","doi-asserted-by":"crossref","first-page":"13509","DOI":"10.1038\/s41598-021-92731-w","article-title":"Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia","volume":"11","author":"Gam\u00f3n","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.sjpmh.2026.01.002_bib0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.31766\/revpsij.v37n4a1","article-title":"Las indicaciones conforme a ficha t\u00e9cnica de los psicof\u00e1rmacos prescritos en psiquiatr\u00eda del ni\u00f1o y del adolescente. Revisi\u00f3n, actualizaci\u00f3n, uso \u201cfuera de ficha\u201d y consideraciones legales","volume":"37","author":"Dualde Beltr\u00e1n","year":"2020","journal-title":"Rev Psiquiatr Infanto Juv"},{"key":"10.1016\/j.sjpmh.2026.01.002_bib0195","doi-asserted-by":"crossref","DOI":"10.1017\/S2045796020000293","article-title":"Use of APs in children and adolescents: a picture from the ARITMO population-based European cohort study","volume":"29","author":"Kaguelidou","year":"2020","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.sjpmh.2026.01.002_bib0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13034-017-0192-1","article-title":"A multi-national comparison of antipsychotic drug use in children and adolescents, 2005\u20132012","volume":"11","author":"Kalverdijk","year":"2017","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"10","key":"10.1016\/j.sjpmh.2026.01.002_bib0205","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.euroneuro.2017.07.001","article-title":"International trends in antipsychotic use: a study in 16 countries, 2005\u20132014","volume":"27","author":"H\u00e1lfd\u00e1narson","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.sjpmh.2026.01.002_bib0210","unstructured":"Report of Antipsychotic Use in Spain. Spanish Agency of Medicines and Medical Devices. Available from: https:\/\/app.powerbi.com\/view?r=eyJrIjoiMmNmZWRhZTItOTY4NC00MzM0LThhYTktZWIwYmU1MjM5ZDM1IiwidCI6IjJkM2I1MGUwLTZlZjQtNGViYy05MjQ2LTdkMWNiYjc3MDg5YyIsImMiOjh9. Accessed 4 April 2025."},{"issue":"3","key":"10.1016\/j.sjpmh.2026.01.002_bib0215","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ije\/dyz266","article-title":"Data resource profile: the Valencia health system integrated database (VID)","volume":"49","author":"Garc\u00eda-Sempere","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.sjpmh.2026.01.002_bib0220","unstructured":"ChlorpromazineR: Convert Antipsychotic Doses to Chlorpromazine Equivalents. Available from: https:\/\/cran.r-project.org\/web\/packages\/chlorpromazineR\/index.html. Accessed 2 April 2025."},{"issue":"2","key":"10.1016\/j.sjpmh.2026.01.002_bib0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S2215-0366(22)00404-7","article-title":"Trends in antipsychotic prescribing to children and adolescents in England: cohort study using 2000\u201319 primary care data","volume":"10","author":"Radoj\u010di\u0107","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"10.1016\/j.sjpmh.2026.01.002_bib0230","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s00213-021-05809-8","article-title":"Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10-year population-based study","volume":"238","author":"G\u00f3mez-Lumbreras","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.sjpmh.2026.01.002_bib0235","first-page":"329","article-title":"Het gebruik van antipsychotica bij kinderen en jongeren in Belgi\u00eb, 2005-2014","volume":"59","author":"Deboosere","year":"2017","journal-title":"Tijdschr Psychiatr"},{"key":"10.1016\/j.sjpmh.2026.01.002_bib0240","doi-asserted-by":"crossref","first-page":"1264047","DOI":"10.3389\/fpsyt.2023.1264047","article-title":"Trends in antipsychotic use among children and adolescents in Germany: a study using 2011\u20132020 nationwide outpatient claims data","volume":"14","author":"D\u00f6rks","year":"2023","journal-title":"Front Psychiatry"},{"issue":"8","key":"10.1016\/j.sjpmh.2026.01.002_bib0245","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1007\/s00787-023-02340-3","article-title":"Comparison of antipsychotic drug use in children and adolescents in the Netherlands before and during the COVID-19 pandemic","volume":"33","author":"Gangapersad","year":"2024","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.sjpmh.2026.01.002_bib0250","doi-asserted-by":"crossref","first-page":"e247965","DOI":"10.1001\/jamanetworkopen.2024.7965","article-title":"Psychotropic medication prescribing for children and adolescents after the onset of the COVID-19 pandemic","volume":"7","author":"Valtuille","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.sjpmh.2026.01.002_bib0255","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1089\/cap.2022.0037","article-title":"Psychotropic prescriptions during the COVID-19 pandemic among U.S. children and adolescents receiving mental health services","volume":"32","author":"Amill-Rosario","year":"2022","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"10.1016\/j.sjpmh.2026.01.002_bib0260","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13034-023-00684-x","article-title":"The impact of the COVID-19 pandemic on rates of adolescents receiving psychopharmacological medication in Austria","volume":"18","author":"Otter","year":"2024","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"1","key":"10.1016\/j.sjpmh.2026.01.002_bib0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13034-024-00806-z","article-title":"Impact of the COVID-19 health crisis on psychotropic drug use in children and adolescents in France","volume":"18","author":"Couturas","year":"2024","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"5","key":"10.1016\/j.sjpmh.2026.01.002_bib0270","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00228-017-2406-0","article-title":"APs use: 2006\u20132013 trends in prevalence and incidence and characterization of users","volume":"74","author":"Montastruc","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.sjpmh.2026.01.002_bib0275","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/bcp.13945","article-title":"Trends in utilization and dosing of antipsychotic drugs in Scandinavia: comparison of 2006 and 2016","volume":"85","author":"H\u00f8jlund","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sjpmh.2026.01.002_bib0280","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fpsyt.2020.00316","article-title":"New users of APs among children and adolescents in 2008\u20132017: a nationwide register study","volume":"11","author":"Varimo","year":"2020","journal-title":"Front Psychiatry"}],"container-title":["Spanish Journal of Psychiatry and Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950285326000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950285326000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:22:13Z","timestamp":1782490933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950285326000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2950285326000098"],"URL":"https:\/\/doi.org\/10.1016\/j.sjpmh.2026.01.002","relation":{},"ISSN":["2950-2853"],"issn-type":[{"value":"2950-2853","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of antipsychotics in children and adolescents in Spain, 2015\u20132023: A real-world, population-based study","name":"articletitle","label":"Article Title"},{"value":"Spanish Journal of Psychiatry and Mental Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjpmh.2026.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Psiquiatr\u00eda y Salud Mental (SEPSM).","name":"copyright","label":"Copyright"}]}}